Harte Hanks Past Earnings Performance
Past criteria checks 0/6
Harte Hanks has been growing earnings at an average annual rate of 19.4%, while the Media industry saw earnings growing at 5.9% annually. Revenues have been declining at an average rate of 1% per year.
Key information
19.4%
Earnings growth rate
21.6%
EPS growth rate
| Media Industry Growth | 13.2% |
| Revenue growth rate | -1.0% |
| Return on equity | -141.8% |
| Net Margin | -15.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Investors Aren't Entirely Convinced By Harte Hanks, Inc.'s (NASDAQ:HHS) Revenues
Jul 03
With EPS Growth And More, Harte Hanks (NASDAQ:HHS) Makes An Interesting Case
Nov 03Harte Hanks, Inc.'s (NASDAQ:HHS) Intrinsic Value Is Potentially 30% Above Its Share Price
Oct 13Harte Hanks (NASDAQ:HHS) Is Experiencing Growth In Returns On Capital
Jun 08Should You Investigate Harte Hanks, Inc. (NASDAQ:HHS) At US$8.83?
Mar 16Does Harte Hanks (NASDAQ:HHS) Deserve A Spot On Your Watchlist?
Feb 22Are Investors Undervaluing Harte Hanks, Inc. (NASDAQ:HHS) By 22%?
Dec 07If EPS Growth Is Important To You, Harte Hanks (NASDAQ:HHS) Presents An Opportunity
Oct 27Harte Hanks: Good Point To Start Accumulation Again (Technical Analysis)
Sep 27Harte Hanks (NASDAQ:HHS) Could Become A Multi-Bagger
Sep 19Harte Hanks and FEVO announce expanding partnership
Sep 15Harte Hanks: Mean Reversion Imminent, But Still A Buy For Patient Investors
Aug 23Harte Hanks, Inc. (NASDAQ:HHS) Stock Catapults 25% Though Its Price And Business Still Lag The Market
Aug 13Harte Hanks GAAP EPS of $0.52 beats by $0.24, revenue of $48.6M misses by $0.7M
Aug 11What Does Harte Hanks, Inc.'s (NASDAQ:HHS) Share Price Indicate?
Jul 26Harte Hanks: This Top-Rated Micro-Cap Stock Has A Great Growth Potential
Jul 14Harte-Hanks: Deep Valuation And Future Growth Could Double The Stock
May 23Revenue & Expenses Breakdown
How Harte Hanks makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 188 | -30 | 22 | 0 |
| 30 Jun 24 | 187 | -29 | 21 | 0 |
| 31 Mar 24 | 190 | -1 | 21 | 0 |
| 31 Dec 23 | 191 | -2 | 21 | 0 |
| 30 Sep 23 | 197 | 23 | 17 | 0 |
| 30 Jun 23 | 204 | 29 | 22 | 0 |
| 31 Mar 23 | 204 | 32 | 22 | 0 |
| 31 Dec 22 | 206 | 35 | 22 | 0 |
| 30 Sep 22 | 203 | 14 | 21 | 0 |
| 30 Jun 22 | 199 | 12 | 20 | 0 |
| 31 Mar 22 | 200 | 17 | 19 | 0 |
| 31 Dec 21 | 195 | 13 | 18 | 0 |
| 30 Sep 21 | 190 | 12 | 20 | 0 |
| 30 Jun 21 | 188 | 7 | 20 | 0 |
| 31 Mar 21 | 180 | -8 | 20 | 0 |
| 31 Dec 20 | 177 | -2 | 22 | 0 |
| 30 Sep 20 | 182 | -6 | 20 | 0 |
| 30 Jun 20 | 186 | -11 | 21 | 0 |
| 31 Mar 20 | 199 | -9 | 23 | 0 |
| 31 Dec 19 | 218 | -27 | 24 | 0 |
| 30 Sep 19 | 235 | -22 | 25 | 0 |
| 30 Jun 19 | 248 | -26 | 30 | 0 |
| 31 Mar 19 | 263 | -28 | 32 | 0 |
| 31 Dec 18 | 285 | 15 | 34 | 0 |
| 30 Sep 18 | 314 | -16 | 39 | 0 |
| 30 Jun 18 | 345 | -8 | 38 | 0 |
| 31 Mar 18 | 370 | -5 | 39 | 0 |
| 31 Dec 17 | 384 | -42 | 40 | 0 |
| 30 Sep 17 | 394 | -85 | 40 | 0 |
| 30 Jun 17 | 397 | -86 | 43 | 0 |
| 31 Mar 17 | 400 | -90 | 43 | 0 |
| 31 Dec 16 | 404 | -90 | 45 | 0 |
| 30 Sep 16 | 411 | -18 | 47 | 0 |
| 30 Jun 16 | 423 | -188 | 46 | 0 |
| 31 Mar 16 | 434 | -187 | 45 | 0 |
| 31 Dec 15 | 444 | -181 | 45 | 0 |
| 30 Sep 15 | 474 | -170 | 46 | 0 |
| 30 Jun 15 | 499 | 9 | 47 | 0 |
| 31 Mar 15 | 530 | 22 | 51 | 0 |
| 31 Dec 14 | 499 | 14 | 43 | 0 |
| 30 Sep 14 | 559 | 21 | 53 | 0 |
| 30 Jun 14 | 560 | 19 | 53 | 0 |
| 31 Mar 14 | 560 | 20 | 53 | 0 |
| 31 Dec 13 | 560 | 24 | 55 | 0 |
Quality Earnings: HHS is currently unprofitable.
Growing Profit Margin: HHS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HHS is unprofitable, but has reduced losses over the past 5 years at a rate of 19.4% per year.
Accelerating Growth: Unable to compare HHS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HHS is unprofitable, making it difficult to compare its past year earnings growth to the Media industry (32.9%).
Return on Equity
High ROE: HHS has a negative Return on Equity (-141.76%), as it is currently unprofitable.